Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups
Phase 4
- Registration Number
- CTRI/2010/091/000241
- Lead Sponsor
- Bayer Schering Pharma AG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 16000
Inclusion Criteria
All patients with untreated or pretreated diabetes mellitus type 2/ IGT can be included into the study.
No Glucobay® intake within the last 3 months before documentation of initial visit
Exclusion Criteria
contraindication stated in the local Glucobay® product information; warnings and precautions
must be considered.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method